If you are enrolled in a UnitedHealthcare Medicare Advantage plan, please visit this page

ICHANGE provides a comprehensive suite of diagnostic assessments and treatment services tailored to digestive, liver, and metabolic health — with a focus on conditions influenced by excess weight and metabolic dysfunction. Our approach emphasizes personalized evaluation, coordinated care, and a full continuum of therapeutic options that support long-term health.

Inbody® Analysis

During your appointment, we may measure your body composition to understand more about your weight. Body weight is the sum of body fat mass (fat) and lean body mass (muscle). Body composition is a better marker of health than weight alone and will be tracked over time. You can find a more detailed explanation of the most important parts of your report below.

Inbody Analysis

A – Muscle-Fat Analysis

  • Weight—your weight in pounds
  • SMM (skeletal muscle mass)—your muscle in pounds
  • Body fat mass—your body fat in pounds

B – Obesity Analysis

  • BMI (body mass index)—a measure of height to weight
    • A healthy BMI is 18.5–24.9.
    • A BMI >25.0 is considered too high and may be associated with poorer health.
  • PBF (percent body fat)—a measure of your total fat as compared to your total weight
    • A healthy PBF in women is 20.0–30.0 depending on age.
    • A healthy PBF in men is 10.0–25.0 depending on age.

FibroScan®

Fibroscan

For patients with suspected liver steatosis, or “fatty liver,” it’s important to understand their risk of developing progressive liver damage, which is made of scar or “fibrosis.” We use FibroScan®, a non-invasive, specialized ultrasound, along with other imaging and lab tests, to help determine the health of your liver and guide treatment choices. We also use FibroScan® to periodically monitor for improvement or worsening of liver fat and scarring. These markers are used to determine your risk of developing more serious complications of liver disease including cirrhosis, which is when the liver develops a lot of scar tissue and no longer works properly.

Important Things to Know About Your FibroScan®:

  • The measure of liver stiffness and fat content, also known as the CAP score, is reported as an average of ten measurements obtained at the time of the exam.
  • No test is perfect for determining exact liver fat and scar content, but the higher the CAP score, the more fat is estimated in the liver, and the higher the stiffness, the more scarring is estimated in the liver.
  • Certain factors can make readings on a FibroScan® less accurate, including eating within 3–4 hours of the test, which is why we recommend fasting.
  • FibroScan® isn’t the best test for everyone. Our specialists may recommend a different test depending on your anatomy, liver tests or treatment considerations.
  • It takes time to show changes on the FibroScan®, so we monitor trends annually.

Comprehensive Assessment Services

We begin with detailed, personalized evaluations that inform individualized treatment planning:

  • Body Composition Analysis (InBody®): Advanced measurement of body fat, lean muscle mass, and metabolic markers to inform health status and track progress over time. 
  • Liver Health Evaluation (FibroScan® and Other Tests): Non-invasive assessment of liver fat content and fibrosis severity to guide risk stratification and treatment decisions for steatosis and related liver conditions.

These assessments support accurate characterization of metabolic and digestive status and are integrated into longitudinal care planning.

Multidisciplinary Treatment and Support

Based on assessment findings, the ICHANGE team collaborates to design and deliver comprehensive treatment plans that may include:

  • Dietary Counseling and Nutrition Support: Personalized counseling from registered dietitians via in-person or telehealth sessions, with no additional out-of-pocket cost for dietitian services. 
  • Exercise and Lifestyle Planning: Customized physical activity guidance designed to enhance weight loss, improve metabolic health, and support long-term movement goals. 
  • Anti-Obesity Medication Management: Evidence-based use of anti-obesity medications selected and optimized to improve treatment response and support lifestyle changes. 
  • Weight Loss Procedures: Minimally invasive endoscopic bariatric procedures coordinated with specialty providers, as appropriate, to support sustained weight reduction.

Integrated Care Delivery

Services are delivered within a coordinated structure that fosters efficient access to multidisciplinary expertise — including gastroenterology, hepatology, endocrinology, cardiology, bariatric surgery, and nutrition. Personalized treatment plans are regularly reviewed and adjusted to reflect clinical progress and patient goals.

Dr. Sonal Kumar uses a FibroScan.

Dr. Sonal Kumar uses a FibroScan